ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-30
DOI
10.1186/s13046-018-0919-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
- (2018) Xu Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Atf3 deficiency promotes genome instability and spontaneous tumorigenesis in mice
- (2017) Z Wang et al. ONCOGENE
- Activating transcription factor 3 represses cigarette smoke-induced IL6 and IL8 expression via suppressing NF-κB activation
- (2017) Yan-ping Wu et al. TOXICOLOGY LETTERS
- Damage-induced neuronal endopeptidase (DINE) enhances axonal regeneration potential of retinal ganglion cells after optic nerve injury
- (2017) Aoi Kaneko et al. Cell Death & Disease
- Activating transcription factor 3 promotes malignance of lung cancer cells in vitro
- (2017) Xuebing Li et al. Thoracic Cancer
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma
- (2016) Masaki Ri INTERNATIONAL JOURNAL OF HEMATOLOGY
- Activating Transcription Factor 3 Expression as a Marker of Response to the Histone Deacetylase Inhibitor Pracinostat
- (2016) Dhanya Sooraj et al. MOLECULAR CANCER THERAPEUTICS
- ATF3 suppresses ESCC via downregulation of ID1
- (2016) Jian Li et al. Oncology Letters
- Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non–Small Cell Lung Carcinoma Cells
- (2016) Jair Bar et al. NEOPLASIA
- YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma
- (2016) Michael J. LaQuaglia et al. Scientific Reports
- The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation
- (2015) C-C Chen et al. ONCOGENE
- Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5+CK8+ epithelial cells
- (2015) Z Wang et al. ONCOGENE
- Role of Activating Transcription Factor 3 (ATF3) in Endoplasmic Reticulum (ER) Stress-induced Sensitization of p53-deficient Human Colon Cancer Cells to Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis through Up-regulation of Death Receptor 5 (DR5) by Zerumbone and Celecoxib
- (2014) Makoto Edagawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model
- (2014) Z Wang et al. ONCOGENE
- Low expression of activating transcription factor 3 in human hepatocellular carcinoma and its clinicopathological significance
- (2014) Li Xiaoyan et al. PATHOLOGY RESEARCH AND PRACTICE
- Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells
- (2014) J Yan et al. Cell Death & Disease
- Induction of DNA damage and ATF3 by retigeric acid B, a novel topoisomerase II inhibitor, promotes apoptosis in prostate cancer cells
- (2013) Yongqing Liu et al. CANCER LETTERS
- ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton
- (2013) X. Yuan et al. CANCER RESEARCH
- Cyr61/CCN1 Is Regulated by Wnt/β-Catenin Signaling and Plays an Important Role in the Progression of Hepatocellular Carcinoma
- (2012) Zhi-Qiang Li et al. PLoS One
- Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin β1 signaling in human hepatocellular carcinoma
- (2011) Hong Li et al. HEPATOLOGY
- Apoptosis in cancer: from pathogenesis to treatment
- (2011) Rebecca SY Wong JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
- (2011) Joon-Il Jun et al. NATURE REVIEWS DRUG DISCOVERY
- Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells
- (2011) K Taketani et al. ONCOGENE
- Opposing roles for calcineurin and ATF3 in squamous skin cancer
- (2010) Xunwei Wu et al. NATURE
- The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing
- (2010) Joon-Il Jun et al. NATURE CELL BIOLOGY
- Fas-Mediated Apoptosis Is Regulated by the Extracellular Matrix Protein CCN1 (CYR61) In Vitro and In Vivo
- (2009) V. Juric et al. MOLECULAR AND CELLULAR BIOLOGY
- Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells
- (2008) Ze Tian et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response
- (2007) Ping Feng et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started